Latest News

As we look back over the past year and forward to the future, we are grateful to our valued customers and partners, and the trust they place in us is our greatest gift. 🎁 But without our employees, nothing would be possible. That's why we thank everyone at ETAP-Lab, STROK@lliance and SYNCROSOME. We appreciate their dedication, passion and positive attitude on every day. With our teams growing, we're convinced that this new year will be a great one ! We look forward to

To prepare for tomorrow's industrial champions in healthcare, France is investing in its promising companies! We have been selected to join the Healthcare Industries and Technologies Accelerator, a selective, targeted and personalized program operated by Bpifrance as part of France 2030 to support innovative companies with high growth potential.   This program - financed by the French Ministry of the Economy, Finance and Industrial and Digital Sovereignty - will support the growth of 12 innovative French companies in the healthcare sector. They

📌ETAP-Lab is delighted to present for the first time a poster at the American Heart Association’s annual International Stroke Conference 2025, in Los Angeles, CA from February 5 to 7, 2025. As a leading international conference in cerebrovascular disease and brain health, the AHA's International Stroke Conference was the ideal platform to highlight our preclinical stroke research expertise.   ETAP-Lab, preclinical efficacy CRO, will be presenting its poster on original preclinical results about in vivo trials on Stroke disease.   📅Meet our expert during the

We are delighted to announce the renewal of ETAP-Lab's ISO 9001 certification. This achievement underlines our commitment to providing exemplary preclinical research services.   A commitment to quality and customer satisfaction   Our robust quality management system, backed by our ISO9001 certification, ensures to our customers: compliance with rigorous quality standards: we follow established protocols and guidelines to ensure the accuracy and reliability of our services. Continuous improvement: We constantly focus on improving our processes and services, driven by a commitment to excellence. Customer-focused

🌍ETAP-Lab is happy to present a poster at the 16th World Stroke Congress (WSC 2024) in Abu Dhabi, UAE, from October 23-26, 2024 organized by the World Stroke Organization.   ETAP-Lab's team is looking forward to attending this global event that explores "the forefront of stroke and cerebrovascular disease topics and present the most influential late breaking clinical trials". As a preclinical efficacy CRO, ETAP-Lab will unveil its poster on original preclinical results about in vivo assays on Stroke disease. The results presented

Better than any certification, at ETAP-Lab we believe that customer recognition is the ultimate goal. We're proud to announce our strategic partnership with Kisolite Corp, a leader in innovative therapeutic solutions. Together, we're advancing in vivo studies for their treatment targeting Inflammatory Bowel Disease (IBD). Our dedication to building lasting relationships goes beyond expertise. Our flexible and human-sized organization offers personalized support, ensuring clients feel empowered throughout the research process.   Ready to collaborate on your next drug efficacy study? Contact us today

📌ETAP-Lab's team will attend the upcoming NEUROSCIENCE 2024 from Saturday, October 5 to Wednesday, October 9, in Chicago (IL, USA), in McCormick Place Convention Center. That meeting is the World's Largest Neuroscience Conference, organized by the Society For Neuroscience (SFN), and with an exciting programming for the scientists coming from around the world!   ETAP-Lab will unveil two posters on original preclinical results about in vitro and in vivo assays on Alzheimer's disease.   📅Let's meet our scientists during the poster sessions   Nicolas Violle, CEO

Inauguration of the STROK@LLIANCE building in the presence of local officials in Caen CAEN - ETAP-Lab, an independent French contract research organization (CRO), will inaugurate its new research laboratory, STROK@LLIANCE, on September 17, 2024, at 14:30. The event will take place on the Jules Horowitz campus in Caen, with the participation of its partners and representatives from the University of Caen-Normandy, Caen la Mer, and the Normandy Region.   A multi-voice ceremony For this inauguration ceremony at STROK@LLIANCE, Nicolas Violle, CEO of ETAP-Lab,

ETAP-Lab will attend the upcoming NLSDays on next September 18 - 19, 2024, in Malmö, Sweden for partnering opportunities. We are delighted to participate for the first time to Nordic Life Science Days, the largest Nordic partnering conference dedicated to the life science industry.   🎯 Explore our wide range of services, from gold-standard to tailored models designed to tackle your challenges You look forward accelerating & derisking the development of your drugs and/or medical devices in Dermatology, Neurology, or Cardiology thanks to preclinical

ETAP-Lab will showcase its expertise at the 53rd ANNUAL ESDR MEETING on next September 4-7, 2024, in Lisbon (Portugal), organized by the European Society for Dermatological Research.   🎯 Discover our gold standard models and our tailored solutions to meet your specific challenges! At ETAP-Lab, French preclinical CRO for over 30 years, we offer in vivo preclinical research services in Dermatology field. Leveraging our gold standard models and tailor-made solutions, we address your challenges in molecule development, spanning across areas such as psoriasis, atopic